Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Benhamou

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Cell Transplantation|November 22, 2025
Cell therapy for type 1 diabetes: Tracing historical progress and exploring emerging technologiesQuentin Perrier, Sandrine Lablanche, Pierre-Yves Benhamou
Journal of Virology|February 28, 2006
Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variantsOlivier Lada, Yves Benhamou, Thierry Poynard, et al.
Comparative Hepatology|January 13, 2006
Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutantVlad Ratziu, Vincent Thibault, Yves Benhamou, et al.
Journal of Hepatology|December 20, 2005
Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus ConferenceDominique Salmon, Mathieu Robain, Jurgen K Rockstroh, et al.
Journal of Diabetes Science and Technology|December 19, 2025
Impact of Algorithmic Modifications Targeting the Meal Period and the Management of Hypoglycemia and Hyperglycemia in Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin Delivery: A Two-Step Observational ReportPierre-Yves Benhamou, Aurélien Vesin, Lucile Reynaud, et al.
Diabetes Technology & Therapeutics|September 25, 2025
A Retrospective Real-Life Study to Compare Glycemic Control Between Simplified Meal Size Estimation and Precise Carbohydrates Counting in Type 1 Diabetes Patients Using DBLG1 Hybrid Closed-Loop SystemJulie Blervaque, Aurélien Vésin, Pierre-Yves Benhamou, et al.
Acta Diabetologica|March 10, 2018
Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop studyPierre Yves Benhamou, Erik Huneker, Sylvia Franc, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2008
Chronic hepatitis B: preventing, detecting, and managing viral resistanceEmmet B Keeffe, Douglas T Dieterich, Jean-Michel Pawlotsky, et al.
AIDS (London, England)|December 4, 2004
Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis CPaula Braitstein, Anita Palepu, Douglas Dieterich, et al.
Antiviral Therapy|July 21, 2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovirOlivier Lada, Yves Benhamou, Annie Cahour, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Cell Transplantation|November 22, 2025
Cell therapy for type 1 diabetes: Tracing historical progress and exploring emerging technologiesQuentin Perrier, Sandrine Lablanche, Pierre-Yves Benhamou
Journal of Virology|February 28, 2006
Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variantsOlivier Lada, Yves Benhamou, Thierry Poynard, et al.
Comparative Hepatology|January 13, 2006
Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutantVlad Ratziu, Vincent Thibault, Yves Benhamou, et al.
Journal of Hepatology|December 20, 2005
Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus ConferenceDominique Salmon, Mathieu Robain, Jurgen K Rockstroh, et al.
Journal of Diabetes Science and Technology|December 19, 2025
Impact of Algorithmic Modifications Targeting the Meal Period and the Management of Hypoglycemia and Hyperglycemia in Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin Delivery: A Two-Step Observational ReportPierre-Yves Benhamou, Aurélien Vesin, Lucile Reynaud, et al.
Diabetes Technology & Therapeutics|September 25, 2025
A Retrospective Real-Life Study to Compare Glycemic Control Between Simplified Meal Size Estimation and Precise Carbohydrates Counting in Type 1 Diabetes Patients Using DBLG1 Hybrid Closed-Loop SystemJulie Blervaque, Aurélien Vésin, Pierre-Yves Benhamou, et al.
Acta Diabetologica|March 10, 2018
Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop studyPierre Yves Benhamou, Erik Huneker, Sylvia Franc, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 11, 2008
Chronic hepatitis B: preventing, detecting, and managing viral resistanceEmmet B Keeffe, Douglas T Dieterich, Jean-Michel Pawlotsky, et al.
AIDS (London, England)|December 4, 2004
Special considerations in the initiation and management of antiretroviral therapy in individuals coinfected with HIV and hepatitis CPaula Braitstein, Anita Palepu, Douglas Dieterich, et al.
Antiviral Therapy|July 21, 2004
In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovirOlivier Lada, Yves Benhamou, Annie Cahour, et al.
Pageof 17